The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Sanofi and Regeneron's fully human monoclonal antibody Dupixent (dupilumab) has gained approval from the US Food and Drug ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

The FDA is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...